substance p has been researched along with Seizures in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (28.00) | 18.7374 |
| 1990's | 11 (44.00) | 18.2507 |
| 2000's | 3 (12.00) | 29.6817 |
| 2010's | 4 (16.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gunes, H; Kilinc, E | 1 |
| Connolly, BS; Hazrati, LN; Lang, AE | 1 |
| Coveñas, R; Muñoz, M | 1 |
| Itakura, T; Miki, J; Nishibayashi, H; Ogura, M; Taguchi, M; Uematsu, Y | 1 |
| Eckols, KT; Firozgary, B; Garza, A; Goodman, JC; Robinson, P; Serpa, JA; Tweardy, DJ; Weinstock, J | 1 |
| Dournaud, P; Fontaine, RH; Gressens, P; Lebas, F; Lelièvre, V; Leroux, P; Medja, F; Ouimet, T; Rougeot, C; Saria, A | 1 |
| Costa, E; Gillin, JC; Hong, JS; Wood, PL; Yang, HY | 1 |
| Huston, JP; Klapdor, K; Sprick, U | 1 |
| Baskin, SI; Lempka, JC; Nealley, EW | 1 |
| Brené, S; Lindefors, N; Zachrisson, O | 1 |
| Berdiev, RK; Chepurnov, SA; Chepurnova, NE | 1 |
| Gonzalez-Nicolini, V; McGinty, JF | 1 |
| Huković, S; Radivojević, M; Stern, P | 1 |
| Bellmann, R; Krause, JE; Marksteiner, J; Ortler, M; Sperk, G; Wahler, R | 1 |
| Mathé, AA; Srinivasan, GR; Stenfors, C; Theodorsson, E | 1 |
| Churchill, L; Cross, RS; Heimer, L; Kalivas, PW; Nelson, SR; Pazdernik, TL; Zahm, DS | 1 |
| Humpel, C; Marksteiner, J; Saria, A; Sperk, G | 1 |
| Casey, SJ; Gaumann, DM; Grabow, TS; Rodriguez, M; Yaksh, TL | 1 |
| Kuang, P; Lang, S; Liu, J; Wu, W; Zhang, F | 1 |
| Chiang, CH; Chiang, W; Ko, FJ; Liu, WJ | 1 |
| Singer, EA; Sperk, G; Widmann, R; Wieser, R | 1 |
| Gale, K; Garant, DS; Iadarola, MJ | 1 |
| Faraci, FM; Heistad, DD; Kadel, KA | 1 |
| Imaizumi, M; Kataoka, K; Kawaguchi, S; Shio, H | 1 |
| Srebocan, S; Stern, P | 1 |
1 review(s) available for substance p and Seizures
| Article | Year |
|---|---|
Involvement of substance P and the NK-1 receptor in human pathology.
Topics: Alcoholism; Animals; Bacterial Infections; Depression; Humans; Inflammation; Migraine Disorders; Neoplasms; Pain; Receptors, Neurokinin-1; Seizures; Stress, Psychological; Substance P; Virus Diseases; Vomiting | 2014 |
24 other study(ies) available for substance p and Seizures
| Article | Year |
|---|---|
Modulatory effects of neuropeptides on pentylenetetrazol-induced epileptic seizures and neuroinflammation in rats.
Topics: Animals; Biomarkers; Calcitonin Gene-Related Peptide; Convulsants; Disease Models, Animal; Ghrelin; Inflammation; Interleukin-1beta; Male; Myoclonus; Neuropeptides; Pentylenetetrazole; Peptide Hormones; Random Allocation; Rats, Wistar; Seizures; Substance P; Time Factors; Vasoactive Intestinal Peptide | 2019 |
Neuropathological findings in chorea-acanthocytosis: new insights into mechanisms underlying parkinsonism and seizures.
Topics: Adult; Brain; Cognition Disorders; Enkephalin, Methionine; Family Health; Humans; Male; Middle Aged; Neuroacanthocytosis; Neurons; Seizures; Substance P; Vesicular Transport Proteins | 2014 |
Nondominant parietotemporal cortical dysplasia manifesting as hypermotor seizures.
Topics: Adult; Electroencephalography; Humans; Magnetic Resonance Imaging; Male; Malformations of Cortical Development; Neurofilament Proteins; Peptide Fragments; Seizures; Substance P | 2009 |
Substance P causes seizures in neurocysticercosis.
Topics: Animals; Brain; Brain Diseases; Disease Models, Animal; Female; Gene Deletion; Granuloma; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Neurocysticercosis; Neurokinin-1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Neurokinin-1; Seizures; Substance P; Taenia | 2012 |
Thiorphan, a neutral endopeptidase inhibitor used for diarrhoea, is neuroprotective in newborn mice.
Topics: Animals; Animals, Newborn; Caspase 3; Cell Death; Cells, Cultured; Cerebral Cortex; Cerebral Palsy; Excitatory Amino Acid Agonists; Female; Ibotenic Acid; Immunohistochemistry; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Neprilysin; Neurokinin A; Neurokinin-1 Receptor Antagonists; Neurons; Neuroprotective Agents; Neurotransmitter Agents; Protease Inhibitors; Receptors, Neurokinin-2; Seizures; Substance P; Thiorphan | 2006 |
Recurrent convulsions and hippocampal [Met5]-enkephalin content.
Topics: Animals; Electroshock; Endorphins; Enkephalin, Methionine; Enkephalins; Hippocampus; Injections; Kainic Acid; Male; Neurons; Rats; Recurrence; Seizures; Substance P; Time Factors | 1980 |
Attenuation of hippocampal kainic acid-induced seizures by substance P treatment.
Topics: Animals; Fetal Tissue Transplantation; Hippocampus; Kainic Acid; Male; Rats; Rats, Wistar; Seizures; Substance P | 1994 |
The effects of EDRF/NO releasers or calcium ionophore A23187 on cyanide toxicity in mice.
Topics: Animals; Bradykinin; Calcimycin; Carbachol; Cyanides; Hydralazine; Ionophores; Lethal Dose 50; Male; Mice; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Platelet Activating Factor; Seizures; Substance P; Survival Rate | 1996 |
A tachykinin NK1 receptor antagonist, CP-122,721-1, attenuates kainic acid-induced seizure activity.
Topics: Animals; Cell Survival; Corpus Striatum; Hippocampus; Kainic Acid; Kinetics; Male; Neurokinin-1 Receptor Antagonists; Piperidines; Protein Precursors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Seizures; Substance P; Tachykinins; Time Factors; Transcription, Genetic | 1998 |
Galanin controls excitability of the brain.
Topics: Animals; Brain; Cerebral Ventricles; Convulsants; Galanin; Glutamic Acid; Injections, Intraventricular; Male; Pentylenetetrazole; Rats; Seizures; Substance P | 1998 |
NK-1 receptor blockade decreases amphetamine-induced behavior and neuropeptide mRNA expression in the striatum.
Topics: Acetamides; Amphetamine; Animals; Area Under Curve; Behavior, Animal; Central Nervous System Stimulants; Corpus Striatum; Dynorphins; Gene Expression Regulation; In Situ Hybridization; Male; Microinjections; Motor Activity; Neurokinin-1 Receptor Antagonists; Neuropeptides; Protein Precursors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Seizures; Sleep; Substance P | 2002 |
[The inhibition of the effects of morphine by synthetic substance P (author's transl)].
Topics: Amphetamine; Animals; Mice; Morphine; Naloxone; Pentylenetetrazole; Receptors, Opioid; Seizures; Substance P | 1976 |
Limbic seizures cause pronounced changes in the expression of neurokinin B in the hippocampus of the rat.
Topics: Animals; Hippocampus; Immunohistochemistry; Kainic Acid; Limbic System; Male; Neurokinin B; Nucleic Acid Hybridization; Pentylenetetrazole; Rats; Rats, Sprague-Dawley; RNA, Messenger; Seizures; Substance P; Tachykinins | 1992 |
Electroconvulsive stimuli and brain peptides: effect of modification of seizure duration on neuropeptide Y, neurokinin A, substance P and neurotensin.
Topics: Animals; Brain; Diazepam; Eicosanoids; Electroshock; Male; Neurokinin A; Neuropeptide Y; Neuropeptides; Neurotensin; Rats; Rats, Sprague-Dawley; Seizures; Substance P; Time Factors; Tissue Distribution | 1992 |
Patterns of glucose use after bicuculline-induced convulsions in relationship to gamma-aminobutyric acid and mu-opioid receptors in the ventral pallidum--functional markers for the ventral pallidum.
Topics: Animals; Autoradiography; Bicuculline; Biomarkers; Globus Pallidus; Glucose; Male; Rats; Rats, Inbred Strains; Receptors, GABA-A; Receptors, Opioid; Receptors, Opioid, mu; Seizures; Substance P | 1992 |
Differential changes in tachykinins after kainic acid-induced seizures in the rat.
Topics: Animals; Brain; Kainic Acid; Male; Radioimmunoassay; Rats; Rats, Inbred Strains; Seizures; Substance P; Tachykinins | 1990 |
Intrathecal somatostatin, somatostatin analogs, substance P analog and dynorphin A cause comparable neurotoxicity in rats.
Topics: Animals; Dynorphins; Injections, Spinal; Male; Motor Activity; Neurotoxins; Octreotide; Pain; Peptide Fragments; Rats; Rats, Inbred Strains; Reference Values; Seizures; Somatostatin; Spinal Cord; Stereotyped Behavior; Substance P; Time Factors | 1990 |
The investigation of antiepileptic action of qingyangshen (QYS)--effect of QYS on the concentrations of neuropeptides in rat brain.
Topics: Animals; Anticonvulsants; Brain; Carbamazepine; Drugs, Chinese Herbal; Male; Neuropeptides; Pentylenetetrazole; Phenytoin; Rats; Rats, Inbred Strains; Seizures; Somatostatin; Substance P | 1991 |
Somatostatin, substance P, prolactin and vasoactive intestinal peptide levels in serum and cerebrospinal fluid of children with seizure disorders.
Topics: Adolescent; Child; Child, Preschool; Humans; Infant; Prolactin; Seizures; Somatostatin; Substance P; Vasoactive Intestinal Peptide | 1991 |
Kainic acid induced seizures: changes in somatostatin, substance P and neurotensin.
Topics: Amygdala; Animals; Brain Chemistry; Chromatography, High Pressure Liquid; Corpus Striatum; Cysteamine; Frontal Lobe; Hippocampus; Kainic Acid; Male; Nerve Tissue Proteins; Neurotensin; Rats; Rats, Inbred Strains; Seizures; Somatostatin; Substance P; Time Factors | 1986 |
Substance P antagonists in substantia nigra are anticonvulsant.
Topics: Animals; Bicuculline; Male; Rats; Rats, Inbred Strains; Seizures; Structure-Activity Relationship; Substance P; Substantia Nigra | 1986 |
Vascular responses of dura mater.
Topics: Adenosine; Animals; Cerebrovascular Circulation; Dogs; Dura Mater; Microspheres; Seizures; Serotonin; Substance P | 1989 |
Substance P and antistrychnine activity.
Topics: Animals; Biological Assay; Brain Chemistry; Cattle; Chromatography; Chromatography, Gel; Gastrointestinal Motility; Guinea Pigs; Ileum; In Vitro Techniques; Mice; Muscle, Smooth; Peptides; Reflex; Seizures; Strychnine; Substance P | 1968 |
The origin of epileptiform seizures caused by oil of Artemisia caerulescens L.
Topics: Aminobenzoates; Animals; Behavior, Animal; Cerebral Decortication; Magnoliopsida; Mephenesin; Mice; Oils; Phenobarbital; Phenylacetates; Phenytoin; Plant Extracts; Respiration; Seizures; Substance P; Urea | 1968 |